Viewing Study NCT03066661


Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2026-01-25 @ 5:36 PM
Study NCT ID: NCT03066661
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2019-04-26
First Post: 2017-02-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module